1. A solid pharmaceutical composition for oral administration in the form of a sprinkler, comprising a plurality of particles, wherein said plurality of particles comprises a first and a second anti-retroviral drugs, and at least one polymer, wherein the first antiretroviral drug is ritonavir.2. A solid pharmaceutical composition for oral administration in the sprinkler form according to Claim. 1, wherein the ritonavir is present in the form of a pharmaceutically acceptable salt, pharmaceutically acceptable solvate, pharmaceutically acceptable hydrate, pharmaceutically acceptable ester, pharmaceutically acceptable enantiomer, pharmaceutically acceptable derivative, pharmaceutically acceptable polymorph, pharmaceutically acceptable prodrug or a pharmaceutically acceptable kompleksa.3. A solid pharmaceutical composition for oral administration in the form of a sprinkler according to Claim. 1, wherein the ritonavir is present in the form of a pharmaceutically acceptable solvata.4. A solid pharmaceutical composition for oral administration in the form of a sprinkler according to Claim. 1, wherein the ritonavir is present in the form of its solvate etanolyatnogo, formamide or partially desolvated solvate solvata.5 formamide. . The solid pharmaceutical composition for oral administration in the form of a sprinkler according to claim 1, wherein the second anti-retroviral drug is a protease inhibitor a nucleoside reverse transcriptase inhibitor nucleotide reverse transcriptase inhibitor non-nucleotidic reverse transcriptase inhibitor integrase inhibitor maturation inhibitor, or any and1. Твердая фармацевтическая композиция для перорального приема в спринклерной форме, содержащая множество частиц, где указанное множество частиц содержит первое и второе антиретровирусные лекарственные средства и по меньшей мере один полимер, где первое антиретровирусное лекарственное средство представляет собой ритонавир.2. Твердая фармацевтическая композиция для перорального приема в спринкл
